Gender Affects Renal Vasoconstrictor Response to Ang I and Ang II

Hypertension

Volumn 31, Issue 1, 1998, Pages 90-96

  Gandhi, Sanjay K ^a   Gainer, Jay ^a   King, Debbie ^a   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; FEMALE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PATHOGENESIS; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SODIUM EXCRETION;

ADULT; ALDOSTERONE; ANALYSIS OF VARIANCE; ANGIOTENSIN I; ANGIOTENSIN II; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; RENAL CIRCULATION; RENIN; SEX CHARACTERISTICS; SINGLE-BLIND METHOD; VASOCONSTRICTION;

EID: 0031892443     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.90     Document Type: Article

References (41)

1. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams R, Hunt SC, Hopkins PN, Hollenberg NK. Nonmodulation as an intermediate phenotype in essential hypertensives. Hypertension. 1992;20:788-796.
2. Hopkins PN, Lifton RP, Hollenberg NK, Juenemaitre X, Hallouin M, Skuppin J, Williams C, Dluhy R, Lalouel J, Williams R, Williams G. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens. 1996;14:199-207.
3. Fisher NDL, Ferri C, Bellini C, Santucci A, Gleason R, Williams GH, Hollenberg NK, Seely EW. Age, gender, and nonmodulation: a sexual dimorphism in essential hypertension. Hypertension. 1997;4:980-985.
4. Abdul-Karim R, Assali NS. Pressor response to angiotonin in pregnant and nonpregnant women. Am J Obstet Gynecol. 1961;82:246-251.
5. Chelsley LC, Talledo E, Bohler CS, Zuspan FP. Vascular reactivity to angiotensin II in pregnant and non-pregnant women. Am J Obstet Gynecol. 1965;91:837-842.
6. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.
7. Ueda S, Elliot HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype DD for angiotensin-converting enzyme. Hypertension. 1995;25:1266-12698.
8. Lachurie M-L, Azizi M, Guyene T-T, Alhenc-Gelas F, Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation. 1995;91:2933-2942.
9. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
10. Regitz-Zagrosek V, Auch-Schwelk W, Neuss M, Fleck E. Regulation of the angiotensin receptor subtypes in cell cultures, animal models and human diseases. Eur Heart J. 1994;15:D92-D97.
11. Linas SL, Ullian ME. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest. 1989;84:840-846.
12. Iwai N, Inagami T. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun. 1992;182:1094-1099.
13. Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest. 1974;54:34-42.
14. Weigley E. Average? Ideal? Desirable? A brief overview of height-weight tables in the United States. J Am Diet Assoc. 1984;84:417-423.
15. Schnurr E, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 1980;13:26-29.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
17. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Ichikawa I, Kon V. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 1996;49:571-577.
18. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
19. Workman RJ, Sussman CR, Burkitt DW, Liddle GW. Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med. 1979;93:847-856.
20. Kubasik NP, Warren K, Sine HE. Evaluation of a new commercial radioimmunoassay kit for aldosterone using an iodinated tracer. Clin Biochem. 1979;10:59-61.
21. Kohara K, Tabuchi Y, Senananyake P, Brosnihan K, Ferrario C. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides. 1991;12:1135-1141.
22. Senananyake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
23. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
24. Brun C. A rapid method for the determination of para-aminohippuric acid in kidney function test. J Lab Clin Med. 1951;37:955-958.
25. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991;18(suppl III):III-126-III-133.
26. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J Hypertens. 1984;2:581-587.
27. Bunnemann B, Fuxe K, Ganten D. The renin-angiotensin system in the brain: an update 1993. Regul Pept. 1993;46:487-509.
28. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Ltd; 1990:1287-1317.
29. Caine AC, Lumbers ER, Reid IA. The effects and interactions of angiotensin and vasopressin on the heart of unanesthetized sheep. J Physiol Lond. 1985;367:1-11.
30. Guo GB, Abboud FM. Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol. 1984;246:H80-H89.
31. Mace PJE, Watson RDS, Skan W, Littler WA. Inhibition of the baroreceptor heart rate reflex by angiotensin II in normal man. Cardiovasc Res. 1985;19:525-527.
32. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol Lond. 1979;294:69-80.
33. Reid IA, Brooks VL, Rudolph CD, Keil LC. Analysis of the actions of angiotensin on the central nervous system of conscious dogs. Am J Physiol. 1982;243:R82-R91.
34. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983;72:2115-2124.
35. Chesley LC, Tepper IH. Effects of progesterone and estrogen on the sensitivity to angiotensin II. J Clin Endocrinol. 1967;27:576-581.
36. Swartz SL, Williams GH, Hollenberg NK, Dluhy RG, Moore TJ. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction. J Clin Endocrinol Metab. 1980;50:1071-1074.
37. Oelkers W, Brown JJ, Fraser R, Lever AF, Moron JJ, Robertson JI. Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res. 1974;40:69-77.
38. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
39. Proudler AJ, Ahmed AH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting enzyme activity in post-menopausal women. Lancet. 1995;346:89-90.
40. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 1987;76:753-758.
41. Schunkert H, Danser JAH, Hense H, Derkx FHM, Kurzinger S, Riegger GAJ. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997;95:39-45.